IXICO PLC Logo

IXICO PLC

IXI | IL

Overview

Corporate Details

ISIN(s):
GB00BFXR4C20 (+1 more)
LEI:
2138005M1F59O6HWSA97
Country:
United Kingdom
Address:
4TH FLOOR, GRIFFIN COURT, EC1A 9PN LONDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IXICO PLC is a clinical research company specializing in neuroscience imaging and biomarker analytics. Established in 2004, the firm provides services and technology to biopharmaceutical companies to support clinical trials for neurological disorders. At its core is a proprietary, AI-driven platform that deploys advanced, disease-specific algorithms to analyze neuroimaging and other clinical data. This generates reliable data and precision insights, enabling clients to accelerate research and development decision-making, de-risk clinical studies, and maximize the potential of their drug development programs. The company's services focus on reducing uncertainties in the discovery, development, and monitoring of new therapies for complex brain diseases.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for IXICO PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 08:00
Regulatory News Service
Contract Win
English 16.3 KB
2025-07-22 08:00
Regulatory News Service
Strategic Data Partnership with GAP
English 22.2 KB
2025-07-17 08:00
Earnings Release
Trading Update
English 16.8 KB
2025-06-13 09:03
Remuneration Information
Share option awards and PDMR Dealing
English 57.1 KB
2025-02-27 08:00
Regulatory News Service
Contract Win
English 15.1 KB
2025-02-12 08:00
Regulatory News Service
Further Validation of IXICO’s AI Imaging Platform
English 20.3 KB
2025-02-07 16:00
Director's Dealing
Issue of share options and PDMR dealing
English 43.7 KB
2025-01-24 15:16
Post-Annual General Meeting Information
Result of AGM
English 30.4 KB
2024-12-16 08:00
Regulatory News Service
Commercial agreement with PETNET Solutions Inc
English 12.6 KB
2024-12-10 08:00
Regulatory News Service
Contract Win
English 14.9 KB
2024-12-04 12:35
Remuneration Information
Share Option Award & PDMR Dealings
English 44.4 KB
2024-12-04 08:00
Earnings Release
Financial Results for year ended 30 September 2024
English 645.2 KB
2024-11-25 08:00
Report Publication Announcement
Notice of Results and Investor Presentation
English 14.7 KB
2024-10-31 08:00
Remuneration Information
Share Option Awards & PDMR Dealing
English 60.7 KB
2024-10-30 17:50
Major Shareholding Notification
Holding(s) in Company
English 52.2 KB

Automate Your Workflow. Get a real-time feed of all IXICO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for IXICO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN